div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: OSS - CORRESPONDENCE REGARDING SENATOR BYRDS VIEWS … src=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: OSS - CORRESPONDENCE REGARDING SENATOR BYRDS VIEWS … src=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: OSS - CORRESPONDENCE REGARDING SENATOR BYRDS VIEWS … src=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: OSS - CORRESPONDENCE REGARDING SENATOR BYRDS VIEWS … src=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: OSS - CORRESPONDENCE REGARDING SENATOR BYRDS VIEWS … src=https:reader030vdocumentsnetreader030viewer202202070161f8657a6429c42e4b67152fhtml5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdiv